AusperBio Therapeutics Secures $73M Series B Funding to Advance Targeted Therapies for Chronic Hepatitis B

AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a privately held clinical-stage biotechnology company dedicated to ...

December 27, 2024 | Friday | News
Valneva and Serum Institute of India Partner to Deliver Asia’s First Single-Shot Chikungunya Vaccine

  Valneva SE (“Valneva” or “the Company”), a specialty vaccine company, and Serum Institute of India (SII), the world’s...

December 19, 2024 | Thursday | News
Nxera Pharma Launches Phase 3 Trial of QUVIVIQ™ (Daridorexant) in South Korea to Address Insomnia Epidemic

Daridorexant is a dual orexin receptor antagonist being developed by Nxera for the treatment of adult patients with insomnia QUVIVIQ™ (daridorex...

December 05, 2024 | Thursday | News
U.S. Bioscience Economy: A Catalyst for Innovation, Economic Growth, and Global Leadership

  The bioscience economy in the United States has evolved into a critical driver of innovation, economic growth, and soci...

December 03, 2024 | Tuesday | Reports
Agilent Drives Strategic Transformation with Strong FY2024 Results, CEO Padraig McDonnell Leads Restructuring for Market Agility and Growth

Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics, and applied chemical markets, has released its financial results for ...

November 26, 2024 | Tuesday | Company results
Merck CEO Belén Garijo Declares Strong Q3 2024 Growth, Reaffirms Path to Profitable 2024 Finish

Net sales up organically by 3.8% to € 5.3 billion EBITDA pre up organically by 16.9% to € 1.6 billion EBITDA ...

November 21, 2024 | Thursday | Company results
Quotient Sciences Installs World’s First GMP Biofoundry-in-a-Box for Accelerated RNA Manufacturing

" Quotient Sciences, in collaboration with Centillion, has installed the revolutionary Biofoundry-in-a-Box (BiaB™) at its Alnwick site, marking a n...

November 20, 2024 | Wednesday | News
TAE Life Sciences and Stella Pharma Announce Exclusive Collaboration to Expand BNCT Therapy in the U.S. and Europe

TAE Life Sciences (TLS), a leader in boron neutron capture therapy (BNCT) technology, and Stella Pharma, the pioneering developer of the boronophenylalan...

November 14, 2024 | Thursday | News
CEO Adam Levy Announces Record-Breaking Q3 Revenue for NEXGEL with 141% Year-Over-Year Growth to $2.94 Million

NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hyd...

November 14, 2024 | Thursday | Company results
23andMe CEO Anne Wojcicki Announces Major Restructuring with 40% Workforce Reduction and Shift Away from Therapeutics

Reduces workforce by roughly 40%; expects annualized cost savings of more than $35 million Discontinues development of therapeutics division and commenc...

November 12, 2024 | Tuesday | News
Ring Therapeutics Strengthens Partnerships with Singapore’s A*STAR and SERI to Advance Gene Therapy for Eye Diseases and Cancer

Ring Therapeutics, a pioneering life sciences company under Flagship Pioneering dedicated to reshaping gene therapy through its unique commensal virome p...

November 05, 2024 | Tuesday | News
CEO Robert Spignesi Leads Rapid Micro Biosystems to Record Q3 Revenue Growth, Achieving 24% Year-Over-Year Increase

Reports record third quarter 2024 revenue of $7.6 million, representing growth of 24%compared to the third quarter of 2023 Placed seven Growth Direct&...

November 04, 2024 | Monday | Company results
Avantor CEO Michael Stubblefield Delivers “Just Another” Stellar Q3, Raises 2024 Free Cash Flow Guidance Again

Net sales of $1.71 billion, decrease of 0.3%; organic decline of 0.7% Net income of $57.8 million; Adjusted EBITDA of $302.5 milli...

October 28, 2024 | Monday | Company results
Thermo Fisher CEO Marc N. Casper Highlights Strong Q3 2024 Results with $10.6 Billion Revenue and Breakthrough Innovations

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, reported its financial results for the third quarter ended September 28, ...

October 24, 2024 | Thursday | Company results

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close